Word

MELIUS MICROBIOMICS

Status

Pending

Status Code

641

Status Date

Monday, April 22, 2024

Serial Number

98157386

Mark Type

4

Filing Date

Wednesday, August 30, 2023

Trademark Owner History

Melius Microbiomics Inc.

Classifications

39 Delivery of prescription drugs

5 Medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of mental health disorders; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; probiotic bacterial formulations for medical purposes; probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system

35 Administering medication reimbursement programs and services; administration and management of research grants; administration of prescription drug programs designed to process medical insurance claims for products used by consumers; administration of prescription drug programs designed to process medical insurance claims for services used by consumers; administrative services for medical referrals; advertising services for promoting public awareness of the benefits of general health and wellness; advertising services for promoting public awareness of the benefits of nutrition; advertising services to promote public awareness of medical conditions; advertising services to promote public awareness on health issues; advertising services to promote public awareness on healthcare issues; analysis of market research data and statistics; assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; business administration of a program to provide access to medicines at low or no cost to underserved populations; business administration of a program to provide discounts on prescription medicines; business administration of medication reimbursement programs and services; business mediation in the purchase and sale of health preparations for medical purposes; collection of medical reports; compilation of medical reports; compilation of statistical data for use in scientific or medical research; consulting services in the field of administrative processing of health insurance claims for health insurers, administrators and payers; consulting services in the field of medical product approval for commercial purposes; consulting services in the field of patient relationship management for healthcare providers; market analysis; market analysis and research; market assessment consultancy; market assessment services; market reports and studies; market research consultancy; market research services; market research studies; market studies; medical billing; medical billing support services; medical cost management; medical records coding services for others for purposes of reimbursement from insurance; medical referrals; on-line retail store services featuring dietary supplements; on-line retail store services featuring dietetic preparations; on-line wholesale store services featuring dietary supplements; on-line wholesale store services featuring dietetic preparations; online and retail sale of prescription drugs

42 Clinical trials; conducting interventional clinical studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research in the fields of clinical trials and post-market trials; scientific research for the development of CRISPR-based platforms and products in the field of genetic engineering; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals; research on the subject of pharmaceuticals

Trademark Events

Sep 2, 2023

New Application Entered

Sep 27, 2023

New Application Office Supplied Data Entered

Apr 19, 2024

Assigned To Examiner

Apr 22, 2024

Non-Final Action Written

Apr 22, 2024

Non-Final Action E-Mailed

Apr 22, 2024

Notification Of Non-Final Action E-Mailed